640 vs L1PA: Side-by-Side Comparison
Compare China Resources Pharmaceutical Group Limited (640) and LEE S PHARMACEUTIC.HD-05 (L1PA) side by side: market cap EUR 2.97B vs EUR 67.84M, P/E 5.9 vs 5.5. Financials, growth and model signals on Bullrun.
| Metric | 640 | L1PA |
|---|---|---|
| Company | China Resources Pharmaceutical Group Limited | LEE S PHARMACEUTIC.HD-05 |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 2.97B | EUR 67.84M |
| P/E ratio | 5.9 | 5.5 |
| Dividend yield | 5.14% | 4.69% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 269.57B | EUR 1.44B |
| Revenue growth YoY | +4.6% | +2.6% |
| Net income | EUR 4.05B | EUR 91.94M |
| Gross margin | 16.5% | 50.8% |
| Diluted EPS | 0.64 | 0.16 |